Loading...
Market
Story
Dark Microglia's Toxic Lipids Linked to Alzheimer's, Offering Potential Therapy
Dec 24, 2024, 07:47 PM
Researchers have identified a new mechanism involving 'dark microglia', a subset of brain immune cells, that may contribute to Alzheimer's disease. This discovery suggests that dark microglia produce and release toxic lipids, which can damage neurons. The study, published in the journal Neuron, indicates that inhibiting this mechanism in mice prevents neurodegeneration. The findings point to potential therapeutic targets for slowing down or even reversing Alzheimer's disease, according to the researchers involved.
View original story
Similar markets
Yes • 50%
No • 50%
Mutation-specific gene therapy • 33%
Universal gene therapy • 33%
No approval • 34%
Moderate improvement • 25%
Significant improvement • 25%
No improvement • 25%
Worse outcomes • 25%
Other • 25%
Johnson & Johnson • 25%
Moderna • 25%
Pfizer • 25%
Other companies • 25%
No dominant company • 25%
Eli Lilly • 25%
Eisai and Biogen • 25%
0-1 new treatments • 25%
2-3 new treatments • 25%
4-5 new treatments • 25%
More than 5 new treatments • 25%
Significant improvement • 25%
Moderate improvement • 25%
No improvement • 25%
Worsening condition • 25%
Donanemab leads • 25%
Leqembi leads • 25%
Both have equal share • 25%
Other treatments lead • 25%
Casgevy leads • 33%
Reni-cel leads • 33%
BEAM-101 leads • 33%
Slightly effective • 25%
Moderately effective • 25%
Not effective • 25%
Highly effective • 25%
Infectious diseases • 25%
Neurological disorders • 25%
Cancer • 25%
Other • 25%